235例复杂性脾切除术的临床疗效

Clinical efficacy of complex splenectomy in 235 patients

  • 摘要: 目的:探讨复杂性脾切除术的临床疗效和手术安全性。
    方法:采用回顾性队列研究方法。收集2005年1月至2015年12月收治的235例(上海交通大学医学院附属瑞金医院135例、上海交通大学附属第一人民医院67例、上海交通大学附属第六人民医院26例、解放军第八五医院7例)复杂性脾切除术患者的临床资料。患者均行全脾切除术,术中先行脾动脉结扎。观察指标:(1)患者手术情况。(2)主要并发症:腹腔内出血、肺部并发症、左膈下脓肿、腹腔积液。(3)随访情况:门静脉系统并发症(随访中脾静脉栓塞性静脉炎、脾静脉栓塞和门静脉主干栓塞),生存情况。采用门诊及电话方式随访,患者定期复查超声、腹部CT、血常规及凝血功能等情况,随访时间截至2016年3月。正态分布的计量资料采用±s表示,计数资料采用 x2检验。
    结果:(1)手术情况:235例患者中,200例患者采用二级脾蒂离断术,35例患者采用非二级脾蒂离断术。235例患者术中出血量为(268±103)mL,脾切除时间为(82±29)min。(2)主要并发症:235例患者中31例出现术后并发症:腹腔内出血12例;肺部并发症17例;3例左膈下脓肿;21例大量腹腔积液,部分患者合并多种症状。上述并发症经再次手术和非手术治疗痊愈。(3)随访情况:门静脉系统并发症:脾静脉栓塞性静脉炎16例;脾静脉栓塞17例;脾静脉栓塞合并门静脉主干栓塞7例;均经抗炎、抗凝和溶栓治疗后好转。血吸虫肝硬化巨脾切除后栓塞率高达32.4%(12/37),而乙型病毒性肝炎肝硬化脾切除后栓塞率为8.1%(12/149),两者比较,差异有统计学意义(χ2=10.9,P<0.05)。生存情况:235例患者中228例获得随访,随访时间为 (7.9±4.2)年。患者一般生存情况良好。
    结论:复杂性脾切除术安全有效,认真仔细的术前评估、精细轻柔的手术操作、脾蒂的正确处理和创面的腹膜化,是降低复杂性脾切除术手术风险的关键环节。

     

    Abstract: Objective:To explore the clinical efficacy and safety of complex splenectomy.
    Methods:The retrospective cohort study was adopted. The clinical data of 235 patients including 135 from Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, 67 from Shanghai Jiaotong University Affiliated First People′s Hospital, 26 from Shanghai Jiaotong University Affiliated Sixth People′s Hospital, 7 from 85 Hospital of PLA who underwent complex splenectomy from January 2005 to December 2015 were collected. All the patients received total splenectomy after splenic artery ligation. The observation indexes included: (1) surgical situations, (2) major complications including intraperitoneal hemorrhage, pulmonary complication, left subphrenic abscess and peritoneal effusion, (3) followup situations: portal vein (PV) complications (splenic venous thrombophlebitis, thrombosis of splenic vein and main portal vein thrombosis), survival of patients. The followup using outpatient examination and telephone interview was performed up to March 2016, and patients received regularly ultrasound reexamination, computed tomography (CT) rescan, routine blood retest and coagulation function. Measurement data with normal distribution were presented as ±s, and count data were analyzed using the chisquare test.
    Results:(1) Surgical situations: of 235 patients, 200 patients underwent secondary spleen pedicle severance and 35 patients underwent nonsecondary spleen pedicle severance. Volume of intraoperative blood loss and duration of splenic resection were (268±103)mL and (82±29)minutes. (2) Major complications: of 31 patients with postoperative complications, intraperitoneal hemorrhage was detected in 12 patients, pulmonary complication in 17 patients, left subphrenic abscess in 3 patients and massive peritoneal effusion in 21 patients. Some patients were combined with multiple symptoms. The patients with above complications were cured after reoperations and nonoperative treatments. (3) Followup situations: PV complications: splenic venous thrombo-phlebitis was detected in 16 patients, thrombosis of splenic vein in 17 patients, thrombosis of splenic vein combined with main portal vein thrombosis in 7 patients, and they were improved after the treatments of antiinflammation, anticoagulation and thrombolysis. The thrombi rate after splenectomy was 32.4%(12/37) in patients with schistosomarelated cirrhosis and 8.1%(12/149) in patients with HBVrelated cirrhosis, with a statistically significant difference (χ2=10.9, P<0.05). Survival of patients: of 235 patients, 228 were followed up for (7.9±4.2)years, with good survival.
    Conclusion:Complex splenectomy is safe and effective, and the key procedure determining the safety of complex splenectomy includes careful preoperative evaluation, delicate surgical technique, proper splenic pedicle severance and peritoneal wounds.

     

/

返回文章
返回